Impact of a multifaceted intervention on non-guideline-recommended prescribing of acid suppressive medications for stress ulcer prophylaxis in critically ill patients

References

• Ali T, Harty RF. Stress-induced ulcer bleeding in critically ill patients. Gastroenterol Clin North Am. 2009;38(2):245–265. doi: 10.1016/j.gtc.2009.03.002.
   PubMed Web of Science ®Google Scholar
• Stollman N, Metz DC. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care. 2005;20(1):35–45. doi: 10.1016/j.jcrc.2004.10.003.
   PubMed Web of Science ®Google Scholar
• Franchitti M, Piubellini J, Sadeghipour F, et al. Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study. Swiss Med Wkly. 2020;150:w20322. 24doi: 10.4414/smw.2020.20322.
   PubMed Web of Science ®Google Scholar
• Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5(6):368–375. doi: 10.1186/cc1071.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;5:486–552.
   Google Scholar
• Armstrong TA, Coursin DB, Devlin J, et al. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347–379.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LA, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. doi: 10.1097/CCM.0000000000002255.
   PubMed Web of Science ®Google Scholar
• Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722. doi: 10.1136/bmj.l6722.
   PubMed Web of Science ®Google Scholar
• Cook D, Heyland D, Griffith L, et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med. 1999;27(12):2812–2817. doi: 10.1097/00003246-199912000-00034.
   PubMed Web of Science ®Google Scholar
• Krag M, Perner A, Wetterslev J, et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015;41(5):833–845. doi: 10.1007/s00134-015-3725-1.
   PubMed Web of Science ®Google Scholar
• Frandah W, Colmer-Hamood J, Nugent K, et al. Patterns of use of prophylaxis for stressrelated mucosal disease in patients admitted to the intensive care unit. J Intensive Care Med. 2014;29(2):96–103. doi: 10.1177/0885066612453542.
   PubMed Web of Science ®Google Scholar
• Wohlt P, Hansen L, Fish J. Inappropriate continuation of stress ulcer prophylactic therapy after discharge. Ann Pharmacother. 2007;41(10):1611–1616. doi: 10.1345/aph.1K227.
   PubMed Web of Science ®Google Scholar
• Hatch J, Schulz L, Fish J. Stress ulcer prophylaxis: reducing nonindicated prescribing after hospital discharge. Ann Pharmacother. 2010;44(10):1565–1571. doi: 10.1345/aph.1P167.
   PubMed Web of Science ®Google Scholar
• Masood U, Sharma A, Bhatti Z, et al. A successful pharmacist-based quality initiative to reduce inappropriate stress ulcer prophylaxis use in an academic medical intensive care unit. Inquiry. 2018;55:46958018759116.
   PubMed Web of Science ®Google Scholar
• Barletta JF, Bruno JJ, Buckley MS, et al. Stress ulcer prophylaxis. Crit Care Med. 2016;44(7):1395–1405. doi: 10.1097/CCM.0000000000001872.
   PubMed Web of Science ®Google Scholar
• Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011–1019. doi: 10.1038/ajg.2012.108.
   PubMed Web of Science ®Google Scholar
• Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391–398. doi: 10.7326/0003-4819-149-6-200809160-00005.
   PubMed Web of Science ®Google Scholar
• Khalili H, Huang ES, Jacobson BC, et al. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 2012;344:e372. doi: 10.1136/bmj.e372.
   PubMed Web of Science ®Google Scholar
• Xie Y, Bowe B, Li T, et al. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2016;27(10):3153–3163. doi: 10.1681/ASN.2015121377.
   PubMed Web of Science ®Google Scholar
• Genta RM. Acid suppression and gastric atrophy: sifting fact from fiction. Gut. 1998;43(Supplement 1):S35–S38. doi: 10.1136/gut.43.2008.S35.
   PubMedGoogle Scholar
• Charlot M, Ahlehoff O, Norgaard ML, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010;153(6):378–386. doi: 10.7326/0003-4819-153-6-201009210-00005.
   PubMed Web of Science ®Google Scholar
• Zhe L, Dandan L, Aiping W, , et al. Investigation on current status of prophylactic medication for stress ulcer during perioperative period in China. Eval Anal Drug-Use Hosp Chin. 2022;22(2):232–236.
   Google Scholar
• Ai-Ping W, Xiao L, Yu M, et al. Retrospective analysis of the use of proton pump inhibitors for stress ulcer prevention in 265 noncritical perioperative patients. Chin J Drug Appl Moni. 2021;18(4):259–262.
   Google Scholar
• Jones CA, Betthauser KD, Lizza 2 B, et al. Impact of stress ulcer prophylaxis discontinuation guidance in mechanically ventilated, critically ill patients: a pre-post cohort study. Hosp Pharm. 2022;57(4):510–517. doi: 10.1177/00185787211061371.
   PubMed Web of Science ®Google Scholar
• Tasaka CL, Burg C, Vanosdol SJ, et al. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units. Ann Pharmacother. 2014;48(4):462–469. doi: 10.1177/1060028013517088.
   PubMed Web of Science ®Google Scholar
• Hammond DA, Killingsworth CA, Painter JT, et al. Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults. Pharm Pract. 2017;15(3):948. doi: 10.18549/PharmPract.2017.03.948.
   PubMedGoogle Scholar
• Hossein K, Simin DK, Azita HHT, et al. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward. J Manage Care Pharma. 2010;16(2):114–121.
   PubMed Web of Science ®Google Scholar
• Shrayteh ZM, Rahal MK, Malaeb DN. Practice of switch from intra venous to oral antibiotics. Springer Plus. 2014;3:717.
   PubMedGoogle Scholar
• Gyawali S, Shankar PR, Saha A, et al. Study of prescription of injectable drugs and intravenous fluids to inpatients in a teaching hospital in Western Nepal. Mcgill J Med. 2009;12:13–20.
   PubMedGoogle Scholar
• Shanshan X, Xin W, Zhihui S, et al. Impact and barriers of a pharmacist-led practice with computerized reminders on intravenous to oral antibiotic conversion for community-acquired pneumonia inpatients. J Clin Pharm Ther. 2021;46(4):1055–1061. doi: 10.1111/jcpt.13397.
   PubMed Web of Science ®Google Scholar
• Buckley MS, Park AS, Anderson CS, et al. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015;128(8):905–913. doi: 10.1016/j.amjmed.2015.02.014.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the european prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA. 1995;274(8):639–644. doi: 10.1001/jama.1995.03530080055041.
   PubMed Web of Science ®Google Scholar
• Anstey MH, Litton E, Palmer RN, et al. Clinical and economic benefits of De-escalating stress ulcer prophylaxis therapy in the intensive care unit: a quality improvement study. Anaesth Intensive Care. 2019;47(6):503–509. doi: 10.1177/0310057X19860972.
   PubMed Web of Science ®Google Scholar
• Li H, Li N, Jia X, et al. Appropriateness and associated factors of stress ulcer prophylaxis for surgical inpatients of orthopedics department in a tertiary hospital: a Cross-Sectional study H. Front in Pharmacol. 2022;13:881063. doi: 10.3389/fphar.2022.881063.
   PubMed Web of Science ®Google Scholar
• Issa IA, Soubra O, Nakkash H, et al. Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis. Dig Dis Sci. 2012;57(10):2633–2641. doi: 10.1007/s10620-012-2104-9.
   PubMed Web of Science ®Google Scholar
• Schepisi R, Fusco S, Sganga F, et al. Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals. J Nutr Health Aging. 2016;20(6):665–670. doi: 10.1007/s12603-015-0642-5.
   PubMed Web of Science ®Google Scholar